Bausch & Lomb Surgical To Commence Catarex Clinical Trials In Mid-1999
This article was originally published in The Gray Sheet
Executive Summary
Bausch & Lomb Surgical will initiate clinical trials to evaluate Optex Ophthalmologics' Catarex cataract-removal system in mid 1999. B&L and Optex parent Atlantic Pharmaceuticals jointly reported May 14 the signing of a multi-year license and development agreement related to the ophthalmic device.